Market Cap
Company Profileargenx Market Cap History
Market Cap: $52.93 Billion
USD as of Aug 2, 2026
Company Profile $ARGXargenx Market Capitalization Over Time
Evolution of argenx SE market cap history
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $209.25 B |
| Vertex Pharmaceuticals | $121.09 B |
| Regeneron Pharmaceuticals | $78.52 B |
| Beigene Ltd. | $51.33 B |
| Marinomed Biotech | $48.98 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
| Lilly | $1.024 T |
| Johnson & Johnson | $617.78 B |
| AbbVie | $443.36 B |
| Roche | $418.93 B |
| UnitedHealth Group | $376.34 B |
Yearly Market Cap Evolution
| Date | Market Cap | YoY Change |
|---|---|---|
| Jan. 1, 2026 | $52.31 B | 34.14% |
| Jan. 1, 2025 | $39.00 B | 69.82% |
| Jan. 1, 2024 | $22.96 B | 9.57% |
| Jan. 1, 2023 | $20.96 B | 38.03% |
| Jan. 1, 2022 | $15.19 B | -8.11% |
| Jan. 1, 2021 | $16.53 B | 103.08% |
| Jan. 1, 2020 | $8.14 B | 35.98% |
| Jan. 1, 2019 | $5.98 B | 36.77% |
| Jan. 1, 2018 | $4.38 B |
Market capitalization is calculated from the opening stock price at the beginning of each year.
Company Description
Profileargenx SE develops and commercializes antibody-based medicines for severe autoimmune diseases, with clinical programs spanning neurology, rheumatology, and hematology.
What is Market Capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.